Capsugel launches enTRinsic drug delivery technology platform

US capsule technology company Capsugel has announced the global launch of its enTRinsic drug delivery technology platform.

The company said the platform provides full enteric protection and targeted release of gastric acid- and heat-sensitive active ingredients to the upper gastrointestinal tract, without the need for functional coatings.

Amit Patel, president, Capsugel Dosage Form Solutions, said: “Capsugel’s enTRinsic drug delivery technology is the result of our continued commitment to innovate for our customers. For years the industry has been searching for a fully enteric dosage form that doesn’t require functional coatings.  By leveraging Capsugel’s unique combination of formulation, polymer chemistry and manufacturing expertise, we have developed a novel solution for enteric protection and the targeted delivery of a wide range of sensitive molecules.”